Company / Tangible Book Value per Share
Sunshine Biopharma Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$9.11
FY2025
5-year range
-$0.55 / $1513.51
FY2021-FY2025
Trend
-99.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $-0.55 in FY2021 to $1513.51 in FY2024.
Based on SEC 10-K filings.
9.11 in FY2025 with a 3-year CAGR of +381.3%.
Improved from $0.96 to $9.11 over the past 2 years.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +381.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 99.4% year-over-year.
- Peak tangible book value per share was recorded in FY2024.
- Lowest tangible book value per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.11 | -99.4% |
| FY2024 | $1513.51 | +157956.0% |
| FY2023 | $0.96 | +1072.3% |
| FY2022 | $0.08 | +114.8% |
| FY2021 | -$0.55 | -2547.7% |
| FY2020 | -$0.02 | -59.9% |
| FY2019 | -$0.01 | +51.7% |
| FY2018 | -$0.03 | -9796.6% |
| FY2017 | -$0.00 | +90.9% |
| FY2016 | -$0.00 | +42.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026